,0
zip,55413
sector,Healthcare
fullTimeEmployees,2700
longBusinessSummary,"Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, and diagnostics and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment provides biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment provides diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and nucleic acid analysis products for use in diagnostic or research applications, as well as instruments and process control products for hematology, blood chemistry, blood gases, and coagulation controls and reagents used in various diagnostic applications. It offers its products under R&D Systems, Novus Biologicals, Tocris Biosciences, ProteinSimple, Advanced Cell Diagnostics, and ExosomeDx brands. Bio-Techne Corporation has a clinical research collaboration with Carterra Inc. for the study of COVID-19 variants. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was founded in 1976 and is headquartered in Minneapolis, Minnesota."
city,Minneapolis
phone,612 379 8854
state,MN
country,United States
companyOfficers,[]
website,https://www.bio-techne.com
maxAge,1
address1,614 McKinley Place N.E.
fax,612 656 4400
industry,Biotechnology
ebitdaMargins,0.32294
profitMargins,0.20447999
grossMargins,0.68188006
operatingCashflow,346312992
revenueGrowth,0.201
operatingMargins,0.26553
ebitda,332496000
targetLowPrice,500
recommendationKey,buy
grossProfits,634415000
freeCashflow,246725504
targetMedianPrice,557
currentPrice,435.45
earningsGrowth,0.687
currentRatio,3.813
returnOnAssets,0.078150004
numberOfAnalystOpinions,10
targetMeanPrice,554.2
debtToEquity,20.912
returnOnEquity,0.12438
targetHighPrice,600
totalCash,278980000
totalDebt,356027008
totalRevenue,1029574976
totalCashPerShare,7.101
financialCurrency,USD
revenuePerShare,26.372
quickRatio,2.79
recommendationMean,1.7
exchange,NMS
shortName,Bio-Techne Corp
longName,Bio-Techne Corporation
exchangeTimezoneName,America/New_York
exchangeTimezoneShortName,EDT
isEsgPopulated,False
gmtOffSetMilliseconds,-14400000
underlyingSymbol,
quoteType,EQUITY
symbol,TECH
underlyingExchangeSymbol,
headSymbol,
messageBoardId,finmb_189488
uuid,0b57ad1b-1e0c-399e-a299-48cc57d56404
market,us_market
annualHoldingsTurnover,
enterpriseToRevenue,16.009
beta3Year,
enterpriseToEbitda,49.573
52WeekChange,
morningStarRiskRating,
forwardEps,9.03
revenueQuarterlyGrowth,
sharesOutstanding,39295300
fundInceptionDate,
annualReportExpenseRatio,
totalAssets,
bookValue,41.743
sharesShort,522510
sharesPercentSharesOut,0.013300001
fundFamily,
lastFiscalYearEnd,1625011200
heldPercentInstitutions,0.95288
netIncomeToCommon,210424000
trailingEps,4.337
lastDividendValue,
SandP52WeekChange,
priceToBook,10.431689
heldPercentInsiders,0.00657
nextFiscalYearEnd,1688083200
yield,
mostRecentQuarter,1640908800
shortRatio,1.54
sharesShortPreviousMonthDate,1642118400
floatShares,39012058
beta,1.221456
enterpriseValue,16482970624
priceHint,2
threeYearAverageReturn,
lastSplitDate,975888000
lastSplitFactor,2:1
legalType,
morningStarOverallRating,
earningsQuarterlyGrowth,0.733
priceToSalesTrailing12Months,16.619616
dateShortInterest,1644883200
pegRatio,4.15
ytdReturn,
forwardPE,48.222595
lastCapGain,
shortPercentOfFloat,0.0152
sharesShortPriorMonth,485076
category,
fiveYearAverageReturn,
previousClose,435.06
regularMarketOpen,438.83
twoHundredDayAverage,462.79465
trailingAnnualDividendYield,0.002942123
payoutRatio,0.2495
volume24Hr,
regularMarketDayHigh,438.83
navPrice,
averageDailyVolume10Day,172600
regularMarketPreviousClose,435.06
fiftyDayAverage,406.928
trailingAnnualDividendRate,1.28
open,438.83
averageVolume10days,172600
expireDate,
algorithm,
dividendRate,1.28
exDividendDate,1644451200
circulatingSupply,
startDate,
regularMarketDayLow,426.26
currency,USD
trailingPE,100.40351
regularMarketVolume,104663
lastMarket,
maxSupply,
openInterest,
marketCap,17111139328
volumeAllCurrencies,
strikePrice,
averageVolume,269606
dayLow,426.26
ask,435.76
askSize,800
volume,104663
fiftyTwoWeekHigh,543.85
fromCurrency,
fiveYearAvgDividendYield,0.64
fiftyTwoWeekLow,347.88
bid,435.21
tradeable,False
dividendYield,0.0031
bidSize,800
dayHigh,438.83
regularMarketPrice,435.45
preMarketPrice,
logo_url,https://logo.clearbit.com/bio-techne.com
